| 2025 | Effect of TNF inhibitors on the risk of cancer recurrence in patients with AS: A nested case-control study | RHEUMATOLOGY |
| 2025 | Development of a new scoring system for predicting recurrent thrombosis in patients with antiphospholipid syndrome | ADVANCES IN RHEUMATOLOGY |
| 2025 | Application of the 2023 ACR/EULAR antiphospholipid syndrome classification criteria to patients fulfilling the 2006 revised Sapporo criteria | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
| 2025 | Factors influencing delayed attainment of low disease activity in rheumatoid arthritis patients continuing targeted therapy
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2025 | Real-world comparative effectiveness study of Janus kinase inhibitors compared to biologic disease-modifying antirheumatic drugs in Korean patients with rheumatoid arthritis | SEMINARS IN ARTHRITIS AND RHEUMATISM |
| 2025 | Targeting eRNA-Producing Super-Enhancers Regulates TNFα Expression and Mitigates Chronic Inflammation in Mice and Patient-Derived Immune Cells
| ADVANCED SCIENCE |
| 2025 | Incidence rates of tuberculosis and inflammatory bowel disease in patients with ankylosing spondylitis treated with biologics in Korea
| RHEUMATOLOGY |
| 2025 | Impact of Early MPO-ANCA Positivity on Unique Clinical Features in Korean Patients with EGPA: A Single-Centre Cohort Study
| MEDICINA-LITHUANIA |
| 2025 | Reply to Sener et al.: Cardiovascular risk according to biological agent exposure in patients with ankylosing spondylitis: A nationwide population-based study | CLINICAL RHEUMATOLOGY |
| 2025 | Risk of Cancers According to the Use of Biological Agents in Patients With Radiographic Axial Spondyloarthritis | JCR-JOURNAL OF CLINICAL RHEUMATOLOGY |
| 2025 | Sex differences in the risk of incident systemic sclerosis: a nationwide population-based study with subgroup analyses
| SCIENTIFIC REPORTS |
| 2025 | Comparative risk of incident and recurrent acute anterior uveitis across different biological agents in patients with ankylosing spondylitis | RHEUMATOLOGY |
| 2025 | Cardiovascular risk according to biological agent exposure in patients with ankylosing spondylitis: a nationwide population-based study | CLINICAL RHEUMATOLOGY |
| 2025 | Association of Immune-Mediated Inflammatory Diseases and Fracture Risk in Patients with Type 2 Diabetes: A Nationwide Population-Based Study
| JOURNAL OF CLINICAL MEDICINE |
| 2024 | Incidence rate of recurrent cardiovascular events in patients with radiographic axial spondyloarthritis and the effect of tumor necrosis factor inhibitors
| ARTHRITIS RESEARCH & THERAPY |
| 2024 | Risk of atrial fibrillation in patients with systemic sclerosis: a nationwide population-based study | RHEUMATOLOGY |
| 2024 | Inequalities in biologics utilization for rheumatoid arthritis according to socioeconomic status
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2024 | Drug survival and change of disease activity using a second janus kinase inhibitor in patients with difficult-to-treat rheumatoid arthritis who failed to a janus kinase inhibitor and subsequent biologics
| ADVANCES IN RHEUMATOLOGY |
| 2024 | 5-aminosalicylic acid suppresses osteoarthritis through the OSCAR-PPARγ axis
| NATURE COMMUNICATIONS |
| 2024 | Corrigendum: Korean treatment recommendations for patients with axial spondyloarthritis
| Journal of Rheumatic Diseases |
| 2024 | Patients with systemic lupus erythematosus who are underweight have distinct disease characteristics | LUPUS |
| 2023 | IgSF11 deficiency alleviates osteoarthritis in mice by suppressing early subchondral bone changes
| EXPERIMENTAL AND MOLECULAR MEDICINE |
| 2023 | Drug Retention Rate and Factors Associated with Discontinuation of Interleukin-17 Inhibitors in Patients with Axial Spondyloarthritis
| YONSEI MEDICAL JOURNAL |
| 2023 | Higher gamma-glutamyl transferase levels are associated with an increased risk of incident systemic sclerosis: a nationwide population-based study
| SCIENTIFIC REPORTS |
| 2023 | Systemic sclerosis is a risk factor of incident psoriasis: results from a nationwide cohort study | FRONTIERS IN IMMUNOLOGY |
| 2023 | Association Between Lipid Profile and Risk of Incident Systemic Sclerosis: A Nationwide Population-Based Study
| CLINICAL EPIDEMIOLOGY |
| 2023 | Risk of kidney failure in patients with systemic sclerosis: a nationwide population-based study
| RMD OPEN |
| 2023 | Korean treatment recommendations for patients with axial spondyloarthritis
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2023 | Comparative effectiveness of JAK inhibitors and biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2023 | Disease course of non-radiographic axial spondyloarthritis: Data from a long-term retrospective observational cohort
| PLOS ONE |
| 2023 | Risk of all-cause and cause-specific mortality associated with immune-mediated inflammatory diseases in Korea
| FRONTIERS IN MEDICINE |
| 2023 | Association of immune-mediated inflammatory diseases with depression and anxiety in patients with type 2 diabetes: A nationwide population-based study
| FRONTIERS IN MEDICINE |
| 2023 | Interleukin-32 as a biomarker in rheumatic diseases: A narrative review
| FRONTIERS IN IMMUNOLOGY |
| 2023 | Risk of systemic lupus erythematosus flares according to autoantibody positivity at the time of diagnosis
| SCIENTIFIC REPORTS |
| 2022 | Correlation between serologic parameters and disease activity of IgG4-related disease: Differences between patients with normal and elevated serum IgG4 concentrations
| FRONTIERS IN IMMUNOLOGY |
| 2022 | Effects of immune-mediated inflammatory diseases on cardiovascular diseases in patients with type 2 diabetes: a nationwide population-based study
| SCIENTIFIC REPORTS |
| 2022 | RISK OF SYSTEMIC LUPUS ERYTHEMATOSUS FLARES ACCORDING TO THE POSITIVITY OF AUTOANTIBODIES | ANNALS OF THE RHEUMATIC DISEASES |
| 2022 | Derivation and Validation of a New Disease Activity Assessment Tool With Higher Accuracy for Takayasu Arteritis
| FRONTIERS IN IMMUNOLOGY |
| 2022 | Effect of tumor necrosis factor inhibitors on risk of cardiovascular disease in patients with axial spondyloarthritis
| ARTHRITIS RESEARCH & THERAPY |
| 2022 | BASDAI cut-off values corresponding to ASDAS cut-off values | RHEUMATOLOGY |
| 2022 | Correlation Between Salivary Microbiome of Parotid Glands and Clinical Features in Primary Sjögren's Syndrome and Non-Sjögren's Sicca Subjects
| FRONTIERS IN IMMUNOLOGY |
| 2022 | Effect of statins on the prevention of recurrent thrombosis in thrombotic antiphospholipid syndrome | RHEUMATOLOGY |
| 2022 | Distinct Gut Microbiota in Patients with Asymptomatic Hyperuricemia: A Potential Protector against Gout Development
| YONSEI MEDICAL JOURNAL |
| 2022 | Selection of X-ray versus magnetic resonance imaging as a first-line imaging modality for diagnosing axial spondyloarthritis
| THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE |
| 2021 | Discovery of urine biomarkers for lupus nephritis via quantitative and comparative proteome analysis
| CLINICAL AND TRANSLATIONAL MEDICINE |
| 2021 | Clinical characteristics of non-radiographic axial spondyloarthritis: Results of the Korean Nonradiographic Axial SPondyloArthritis (KONASPA) data | INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES |
| 2021 | Vascular Uptake on 18 F-FDG PET/CT During the Clinically Inactive State of Takayasu Arteritis Is Associated with a Higher Risk of Relapse
| YONSEI MEDICAL JOURNAL |
| 2021 | Factors affecting drug survival of an alternative TNF inhibitor and secukinumab in patients with ankylosing spondylitis switching from the first TNF inhibitor
| THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE |
| 2021 | Tumour necrosis factor inhibitor tapering in patients with ankylosing spondylitis at low disease activity: factors associated with flare
| THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE |
| 2020 | Non-steroidal anti-inflammatory drugs in patients with stable ankylosing spondylitis receiving tumor necrosis factor inhibitor: continued vs withdrawn | CLINICAL RHEUMATOLOGY |
http://orcid.org/0000-0003-1189-7637
(7404486890)
